Weekly review: Teen caffeine intake, GLP-1 prescriptions, and more

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, May 20, to Friday, May 24, 2024), and click on each link to read and watch anything you may have missed.

1.) Depression not increased by gender identity changes in adolescents

Though gender identity is susceptible to change among youths who identify as a sexual and gender minority (SGM), such changes are not associated with change in depressive symptoms, according to new data.

Click here to read the full article.

2.) Adolescent GLP-1 prescriptions increased 6-fold from 2020 to 2023

The amount of adolescents and young adults receiving GLP-1 receptor agonists including semaglutide (Ozempic) and tirzepatide increased approximately 6-fold from 2020 to 2023, according to findings from a new research letter.

Click here to read the full article.

3.) WHO report highlights challenges and progress in combatting HIV, hepatitis, and STIs worldwide

This report underscores the increase of STIs alongside the ongoing global epidemics of HIV and viral hepatitis in the Americas and African regions.

Click here for the full article.

4.) Survey reveals teens' top caffeine sources and parental concern

A recent poll revealed the caffeine consumption habits of teenagers and the concerns of their parents. The survey, conducted by the C.S. Mott Children’s Hospital National Poll on Children’s Health, targeted parents of children aged 13-18 years, revealing that a significant number of teens regularly consume caffeine, primarily through soda, tea, coffee, and energy drinks.

Click here to read the full article.

5.) How mental health programs can impact symptoms in pediatric patients

In this Q&A, Anne Bird, MD, discusses the results of a recently published study observing the impact Rady Children's Hospital's new mental health program has had on their patients and mental health symptoms.

Click here for the full interview.